These authors contributed equally to this work.
Autoimmune, Cholestatic and Biliary Disease
E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network
Article first published online: 25 JUL 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 3, pages 919–930, September 2014
How to Cite
Zhang, Y., Xu, N., Xu, J., Kong, B., Copple, B., Guo, G. L. and Wang, L. (2014), E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network. Hepatology, 60: 919–930. doi: 10.1002/hep.27121
Potential conflict of interest: Nothing to report.
Supported by NIH DK080440 (to L.W.); American Heart Association 13GRNT14700043 and VA Merit Award 1I01BX002634 (to L.W.).
- Issue published online: 25 AUG 2014
- Article first published online: 25 JUL 2014
- Accepted manuscript online: 11 MAR 2014 10:40PM EST
- Manuscript Accepted: 7 MAR 2014
- Manuscript Received: 23 JAN 2014
Additional Supporting Information may be found in the online version of this article at the publisher's website.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.